How have PPMD shares performed in 2024?

Protide Pharmaceuticals' stock was trading at $0.22 at the start of the year. Since then, PPMD shares have increased by 0.0% and is now trading at $0.22. View the best growth stocks for 2024 here .

How do I buy shares of Protide Pharmaceuticals?

Shares of PPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PPMD

Protide Pharmaceuticals (PPMD) Stock Price, News & Analysis

→ Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad)

Free PPMD Stock Alerts

$0.22

0.00 (0.00%)

(As of 10/21/2022)

Compare

Today's Range: $0.22
▼
$0.22
50-Day Range: $0.22
▼
$0.22
52-Week Range: $0.02
▼
$0.48

Volume: N/A
Average Volume: 6,570 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Protide Pharmaceuticals alerts:

Ad Banyan Hill Publishing

The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

About Protide Pharmaceuticals

Protide Pharmaceuticals, Inc. discovers, develops, and commercializes technologies and processes in the areas of clinical cell therapy, regenerative medicine, transfusion medicine, cell engineering, and transplantation in the United States and internationally. It offers serum reducers, cell culture and processing products, stem cell cryopreservatives, and stem cell and regenerative research products. The company is based in Lake Zurich, Illinois.

PPMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PPMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive PPMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protide Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 5/01/2024
Fiscal Year End: 8/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological Products, Except Diagnostic
Sub-Industry: N/A
Current Symbol: OTCMKTS:PPMD
CUSIP: N/A
CIK: N/A
Web: www.protidepharma.com
Phone: (847) 726-3100
Fax: 651-730-8900
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.20

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Milo R. Polovina (Age 66)
Chairman, CEO, Pres, Principal Financial Officer, Sec. and Treasurer

Key Competitors

View All Competitors

PPMD Stock Analysis - Frequently Asked Questions

How have PPMD shares performed in 2024?: Protide Pharmaceuticals' stock was trading at $0.22 at the start of the year. Since then, PPMD shares have increased by 0.0% and is now trading at $0.22.
View the best growth stocks for 2024 here.
How do I buy shares of Protide Pharmaceuticals?: Shares of PPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PPMD) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial